ID

20671

Descripción

Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX); ODM derived from: https://clinicaltrials.gov/show/NCT00377858

Link

https://clinicaltrials.gov/show/NCT00377858

Palabras clave

Versiones (1)
  1. 9/3/17 9/3/17 -
Subido en

9 de marzo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT00377858

Inglés

Eligibility Diabetes Mellitus, Type 2 NCT00377858

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
have type 2 diabetes
Descripción

Diabetes Mellitus, Non-Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
have been receiving oral antihyperglycemic medications (oam) without insulin including at least two of the following at maximally tolerated doses, and meet the minimum dosing criteria shown: metformin 1500 mg/day, sulfonylurea 1/2 the maximum daily dose, according to package insert, thiazolidinedione (tzd) 30 mg/day pioglitazone or 4 mg/day rosiglitazone. the oams also must be used in accordance with the product label
Descripción

Hypoglycemic Agents Oral | Insulin | Metformin U/day | Sulfonylurea Daily Dose | Thiazolidinediones | pioglitazone U/day | rosiglitazone U/day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020616
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C0021641
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0456683
UMLS CUI [4,1]
C0038766
UMLS CUI [4,2]
C2348070
UMLS CUI [5]
C1257987
UMLS CUI [6,1]
C0071097
UMLS CUI [6,2]
C0456683
UMLS CUI [7,1]
C0289313
UMLS CUI [7,2]
C0456683
have a hemoglobin a1c greater than or equal to 7.5% and less than or equal to 12.0%.
Descripción

Glycosylated hemoglobin A Percentage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019018
UMLS CUI [1,2]
C0439165
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
are taking a tzd dose greater than what is indicated in combination with insulin according to the tzd label.
Descripción

Thiazolidinediones High dose | Insulin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1257987
UMLS CUI [1,2]
C0444956
UMLS CUI [2]
C0021641
are taking any other glucose-lowering agents not mentioned in inclusion criterion.
Descripción

Hypoglycemic Agents

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020616
have taken acarbose, miglitol, pramlintide, exenatide, repaglinide, or nateglinide in the past 6 weeks or for a total of 30 days or more in the last 24 weeks.
Descripción

Acarbose | miglitol | Pramlintide | exenatide | repaglinide | nateglinide

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0050393
UMLS CUI [2]
C0066535
UMLS CUI [3]
C0537551
UMLS CUI [4]
C0167117
UMLS CUI [5]
C0246689
UMLS CUI [6]
C0903898
have a body mass index greater than 40 kg/m2.
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
have had more than one episode of severe hypoglycemia in the last24 weeks
Descripción

Hypoglycemia Severe Episode Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332189
UMLS CUI [1,4]
C1265611
are pregnant, intend to be pregnant during the course of the study or are breastfeeding
Descripción

Pregnancy | Pregnancy, Planned | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3]
C0006147
have clinically significant cardiac, renal, hematologic, oncologic, or hepatic disease
Descripción

Heart Disease | Kidney Disease | Hematological Disease | Malignant Neoplasm | Liver disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0018939
UMLS CUI [4]
C0006826
UMLS CUI [5]
C0023895
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00377858

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
have type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Hypoglycemic Agents Oral | Insulin | Metformin U/day | Sulfonylurea Daily Dose | Thiazolidinediones | pioglitazone U/day | rosiglitazone U/day
Item
have been receiving oral antihyperglycemic medications (oam) without insulin including at least two of the following at maximally tolerated doses, and meet the minimum dosing criteria shown: metformin 1500 mg/day, sulfonylurea 1/2 the maximum daily dose, according to package insert, thiazolidinedione (tzd) 30 mg/day pioglitazone or 4 mg/day rosiglitazone. the oams also must be used in accordance with the product label
boolean
C0020616 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2])
C0025598 (UMLS CUI [3,1])
C0456683 (UMLS CUI [3,2])
C0038766 (UMLS CUI [4,1])
C2348070 (UMLS CUI [4,2])
C1257987 (UMLS CUI [5])
C0071097 (UMLS CUI [6,1])
C0456683 (UMLS CUI [6,2])
C0289313 (UMLS CUI [7,1])
C0456683 (UMLS CUI [7,2])
Glycosylated hemoglobin A Percentage
Item
have a hemoglobin a1c greater than or equal to 7.5% and less than or equal to 12.0%.
boolean
C0019018 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Thiazolidinediones High dose | Insulin
Item
are taking a tzd dose greater than what is indicated in combination with insulin according to the tzd label.
boolean
C1257987 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2])
Hypoglycemic Agents
Item
are taking any other glucose-lowering agents not mentioned in inclusion criterion.
boolean
C0020616 (UMLS CUI [1])
Acarbose | miglitol | Pramlintide | exenatide | repaglinide | nateglinide
Item
have taken acarbose, miglitol, pramlintide, exenatide, repaglinide, or nateglinide in the past 6 weeks or for a total of 30 days or more in the last 24 weeks.
boolean
C0050393 (UMLS CUI [1])
C0066535 (UMLS CUI [2])
C0537551 (UMLS CUI [3])
C0167117 (UMLS CUI [4])
C0246689 (UMLS CUI [5])
C0903898 (UMLS CUI [6])
Body mass index
Item
have a body mass index greater than 40 kg/m2.
boolean
C1305855 (UMLS CUI [1])
Hypoglycemia Severe Episode Quantity
Item
have had more than one episode of severe hypoglycemia in the last24 weeks
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Pregnancy | Pregnancy, Planned | Breast Feeding
Item
are pregnant, intend to be pregnant during the course of the study or are breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Heart Disease | Kidney Disease | Hematological Disease | Malignant Neoplasm | Liver disease
Item
have clinically significant cardiac, renal, hematologic, oncologic, or hepatic disease
boolean
C0018799 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0018939 (UMLS CUI [3])
C0006826 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial